Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2009

58451 1245038400

false

1245038400

1259

469

111

300062

6/15/2009--Introduced.Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2009 or the PATIENTS Act of 2009 - Prohibits the Secretary of Health and Human Services (HHS) from using data obtained from the conduct of comparative effectiveness research, including such research that is conducted or supported using funds appropriated under the American Recovery and Reinvestment Act of 2009, to deny coverage of an item or service under a federal health care program. Requires the Secretary to ensure that comparative effectiveness research conducted or supported by the federal government accounts for factors contributing to differences in the treatment response and preferences of patients, including patient-reported outcomes, genomics and personalized medicine, the unique needs of health disparity populations, and indirect patient benefits.

1245038400

2009-06-15

Wed Jan 06 08:27:37 -0600 2010

introduced

58451

'act':13 'new':8 '2009':15 'access':2 'effect':7 'servic':11 'target':4 'patient':12 'preserv':1 'individu':5 'treatment':9

74717

false

Preserving Access to Targeted, Individualized, and Effective New Treatments and Services (PATIENTS) Act of 2009

short

introduced

58451

'act':2 '2009':4 'patient':1

74716

false

PATIENTS Act of 2009

short

introduced

58451

'use':10 'bill':2 'care':28 'data':12 'deni':19 'item':22 'ensur':32 'feder':26 'advanc':39 'compar':15,34 'differ':44 'effect':16,35 'health':27 'obtain':13 'person':41 'servic':24 'account':37 'coverag':20 'medicin':42 'patient':6,46 'program':29 'protect':4 'respons':48 'prohibit':8 'research':17,36 'treatment':47

74635

false

A bill to protect all patients by prohibiting the use of data obtained from comparative effectiveness research to deny coverage of items or services under Federal health care programs and to ensure that comparative effectiveness research accounts for advancements in personalized medicine and differences in patient treatment response.

official

action

58451

1245038400 Mon Jun 15 00:00:00 -0500 2009 200057

Sponsor introductory remarks on measure. (CR S6582-6585)

K000352 1942-04-25

10339

730 Hart Senate Office Building

http://kyl.senate.gov/contact.cfm

202-224-2207 Jon

'r':4 'az':5 'jon':2,6,8 'kyl':3,7,9 'sen':1

M 300062 Kyl

Jon_Kyl

Sen. Jon Kyl [R, AZ]

5381

N00006406

13585

Republican 202-224-4521 Presbyterian AZ

Sen.

Jon Kyl

3.296875

http://kyl.senate.gov/

SenJonKyl

action

58451

1245038400 Mon Jun 15 00:00:00 -0500 2009 200057

Sponsor introductory remarks on measure. (CR S6582-6585)

action

58451

1245038400 Mon Jun 15 00:00:00 -0500 2009 199342

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

action

58451

1245038400 Mon Jun 15 00:00:00 -0500 2009 199341

Sponsor introductory remarks on measure. (CR S6592-6585)

introduced

58451

1245038400 Mon Jun 15 00:00:00 -0500 2009 199340